Repatha Pushtronex Prices, Coupons and Patient Assistance Programs
Repatha Pushtronex (evolocumab) is a member of the PCSK9 inhibitors drug class and is commonly used for Cardiovascular Risk Reduction, High Cholesterol, High Cholesterol - Familial Heterozygous and others.
Repatha Pushtronex Prices
This Repatha Pushtronex price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Repatha Pushtronex subcutaneous solution (420 mg/3.5 mL) is around $1,272 for a supply of 3.5 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount CardPrint Now
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Repatha Pushtronex Coupons and Rebates
Repatha Pushtronex offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Patient Assistance Programs for Repatha Pushtronex
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
More about Repatha Pushtronex (evolocumab)
- Repatha Pushtronex Side Effects
- During Pregnancy
- Dosage Information
- En Español
- 1 Review
- Drug class: PCSK9 inhibitors